BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Psilocybin in mental healthcare: what we have learnt and where we 
 are going - Dr. Meg Spriggs
DTSTART:20211129T183000Z
DTEND:20211129T200000Z
UID:TALK165373@talks.cam.ac.uk
CONTACT:Bianca De Sanctis
DESCRIPTION:For our next in-person talk of the year\, we're delighted to w
 elcome Dr. Meg Spriggs to talk about her ground-breaking work at the Centr
 e for Psychedelic Research at Imperial College London\, and to give some w
 ider context on the use of psilocybin (the active ingredient in magic mush
 rooms) in psychiatry. Following the talk\, there will be time for question
 s\, and a trip to the pub if anyone is interested.\n\nThis event is being 
 co-hosted by CamBrain: The Cambridge Neuroscience Society - check out thei
 r page here: https://www.facebook.com/CamBrainCNS\n\nThis talk will be a b
 road discussion of what we have learnt and where we are headed in deepenin
 g our understanding of psilocybin in mental healthcare. The talk will focu
 s on trials conducted by the Centre for Psychedelic Research\, Imperial Co
 llege London\, including a recently completed RCT comparing psilocybin to 
 escitalopram in the treatment of major depression\, and our ongoing trial 
 assessing psilocybin as a potential treatment avenue for anorexia nervosa.
  We will explore what past research has taught us about the potential mech
 anisms of this therapeutic approach\, and will finish with a discussion of
  the importance of Public Patient Involvement to the development of the ps
 ychedelic trials of the future.\n\nDr. Meg Spriggs completed her PhD in ps
 ychology at the University of Auckland\, New Zealand\, where she focused o
 n neuroplasticity in Alzheimer’s Disease. Following this\, her passion f
 or mental health research led her to the Centre for Psychedelic Research a
 t Imperial College London. Here she has worked across numerous projects in
 cluding as co-ordinator and guide on a study of the acute and long-term ps
 ychological and neurological effects of psilocybin in healthy volunteers. 
 However\, her main focus since joining the group has been in developing an
 d leading the first study of psilocybin assisted therapy for anorexia nerv
 osa in Europe\, which commenced in May 2021.\n\nThe Cambridge Psychedelic 
 Society was started last year as a platform to encourage discussion and ed
 ucation about psychedelic substances\, their use in medicine\, as well as 
 their cultural\, legal\, philosophical\, and artistic impacts. Everyone we
 lcome. Advertising or soliciting illegal drugs is strictly prohibited.\n\n
 Join our Facebook page here: https://www.facebook.com/psychedelicsoc/
LOCATION:Lightfoot Room\,  Old Divinity School\,  St John’s College
END:VEVENT
END:VCALENDAR